WallStreetZenWallStreetZen

NASDAQ: TRDA
Entrada Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TRDA earnings and revenue history

Current Revenue
$129.0M
Current Earnings
-$6.7M
Current Profit Margin
-5.2%

TRDA Return on Equity

Current Company
-2.9%
Current Industry
-63.5%
Current Market
188%
TRDA's Return on Equity (-2.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TRDA announces earnings.

TRDA Return on Assets

Current Company
-1.4%
Current Industry
2.9%
TRDA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TRDA Return on Capital Employed

Current Company
3.88%
Current Industry
19.5%
TRDA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TRDA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TRDA$129.01M$14.90M-$6.69MN/AN/A
SLRN$0.00-$381.37M-$381.64MN/AN/A
VYGR$250.01M$126.46M$132.33M+101.01%+128.28%
ANNX$0.00-$130.97M-$134.24MN/AN/A
CCCC$20.76M-$121.80M-$132.49M+1.40%N/A
View Top Biotech Stocks

TRDA earnings dates

Next earnings date
Jun 13, 2024

Entrada Therapeutics Earnings & Revenue FAQ

What were TRDA's earnings last quarter?

On Invalid Date, Entrada Therapeutics (NASDAQ: TRDA) reported Q4 2023 earnings per share (EPS) of -$0.29, up 62.82% year over year. Total Entrada Therapeutics earnings for the quarter were -$9.54 million. In the same quarter last year, Entrada Therapeutics's earnings per share (EPS) was -$0.78.

If you're new to stock investing, here's how to buy Entrada Therapeutics stock.

What was TRDA's earnings growth in the past year?

As of Q2 2024, Entrada Therapeutics's earnings has grown year over year. Entrada Therapeutics's earnings in the past year totalled -$6.69 million.

What is TRDA's earnings date?

Entrada Therapeutics's earnings date is Invalid Date. Add TRDA to your watchlist to be reminded of TRDA's next earnings announcement.

What was TRDA's revenue last quarter?

On Invalid Date, Entrada Therapeutics (NASDAQ: TRDA) reported Q4 2023 revenue of $41.85 million up Infinity% year over year. In the same quarter last year, Entrada Therapeutics's revenue was $0.00.

What was TRDA's revenue growth in the past year?

As of Q2 2024, Entrada Therapeutics's revenue has grown null year over year. Entrada Therapeutics's revenue in the past year totalled $129.01 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.